We are live on
!
Find out more
CCP
Cardan Capital Partners Portfolio holdings
AUM
$893M
1-Year Est. Return
22.82%
This Fund
S&P 500
This Quarter
Est. Return
+10.44%
1 Year Est. Return
+22.82%
3 Year Est. Return
+64.04%
5 Year Est. Return
+96.69%
10 Year Est. Return
–
AUM
$810M
AUM Growth
+$57.8M
(+7.7%)
Cap. Flow
-$7.35M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
34.41%
Holding
254
New
18
Increased
85
Reduced
63
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$29M |
| 2 |
Cambria Tail Risk ETF
TAIL
|
+$20.8M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$18.4M |
| 4 |
FOLD
Amicus Therapeutics
FOLD
|
+$7.73M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$3.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$15M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.59M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$5.16M |
| 4 |
First Trust Dow Jones Select MicroCap Index Fund
FDM
|
+$4.64M |
| 5 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$4.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.23% |
| 2 | Technology | 11.85% |
| 3 | Consumer Discretionary | 4.34% |
| 4 | Communication Services | 4.04% |
| 5 | Healthcare | 3.09% |
Similar funds
KFM
DIC
OAM
SIM
LBD
WAM
AG
FMT
Cardan Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Cardan Capital Partners held 254 positions worth $810M, up 7.7% from $753M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cardan Capital Partners's Q4 2020 filing shows 18 new, 85 increased, 63 reduced and 28 closed positions. Its largest new stake was Amicus Therapeutics: 378,141 shares worth $8.73M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $15M.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 73% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cardan Capital Partners's largest Q4 2020 buy was Amicus Therapeutics: 378,141 shares worth $8.73M.
- Cardan Capital Partners added most to iShares 20+ Year Treasury Bond ETF in Q4 2020, an estimated $29M increase.
- Cardan Capital Partners's biggest Q4 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $15M.
- Cardan Capital Partners fully exited Trane Technologies in Q4 2020, selling an estimated $4.1M.
- Cardan Capital Partners's ten largest holdings make up 34% of its $810M portfolio in Q4 2020.
- Cardan Capital Partners opened 18 new positions and closed 28 in Q4 2020.
- Cardan Capital Partners's portfolio value rose 7.7% quarter-over-quarter to $810M.
Based on Cardan Capital Partners's 13F filing for Q4 2020, filed 27 Jan 2021.